Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Conformational analysis of N,N-disubstituted-1,4-diazepane orexin receptor antagonists and implications for receptor binding
Christopher D. Cox, Georgia B. McGaughey, Michael J. Bogusky, et al.
Bioorganic & Medicinal Chemistry Letters (2009) Vol. 19, Iss. 11, pp. 2997-3001
Closed Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Profound Methyl Effects in Drug Discovery and a Call for New CH Methylation Reactions
Heike Schönherr, Tim Cernak
Angewandte Chemie International Edition (2013) Vol. 52, Iss. 47, pp. 12256-12267
Closed Access | Times Cited: 931
Orexin Receptors: Pharmacology and Therapeutic Opportunities
Thomas E. Scammell, Christopher J. Winrow
The Annual Review of Pharmacology and Toxicology (2011) Vol. 51, Iss. 1, pp. 243-266
Open Access | Times Cited: 350
Discovery of the Dual Orexin Receptor Antagonist [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia
Christopher D. Cox, Michael J. Breslin, David B. Whitman, et al.
Journal of Medicinal Chemistry (2010) Vol. 53, Iss. 14, pp. 5320-5332
Closed Access | Times Cited: 348
Crystal structure of the human OX2 orexin receptor bound to the insomnia drug suvorexant
Jie Yin, Juan Carlos Mobarec, Peter Kolb, et al.
Nature (2014) Vol. 519, Iss. 7542, pp. 247-250
Closed Access | Times Cited: 203
Installing the “magic methyl” – C–H methylation in synthesis
Daniya Aynetdinova, Mia Callens, Harry B. Hicks, et al.
Chemical Society Reviews (2021) Vol. 50, Iss. 9, pp. 5517-5563
Open Access | Times Cited: 181
Ausgeprägte Methyleffekte in der Wirkstoff‐Forschung und der Bedarf an neuen C‐H‐Methylierungsreaktionen
Heike Schönherr, Tim Cernak
Angewandte Chemie (2013) Vol. 125, Iss. 47, pp. 12480-12492
Closed Access | Times Cited: 164
International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin Receptor Function, Nomenclature and Pharmacology
Anthony L. Gotter, Andrea L. Webber, Paul J. Coleman, et al.
Pharmacological Reviews (2012) Vol. 64, Iss. 3, pp. 389-420
Closed Access | Times Cited: 154
Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors
Jie Yin, Kerim Babaoglu, Chad A. Brautigam, et al.
Nature Structural & Molecular Biology (2016) Vol. 23, Iss. 4, pp. 293-299
Closed Access | Times Cited: 132
Pharmacological characterization of MK-6096 – A dual orexin receptor antagonist for insomnia
Christopher J. Winrow, Anthony L. Gotter, Christopher D. Cox, et al.
Neuropharmacology (2011) Vol. 62, Iss. 2, pp. 978-987
Closed Access | Times Cited: 121
Discovery of [(2R,5R)‐5‐{[(5‐Fluoropyridin‐2‐yl)oxy]methyl}‐2‐methylpiperidin‐1‐yl][5‐methyl‐2‐(pyrimidin‐2‐yl)phenyl]methanone (MK‐6096): A Dual Orexin Receptor Antagonist with Potent Sleep‐Promoting Properties
Paul J. Coleman, John D. Schreier, Christopher D. Cox, et al.
ChemMedChem (2012) Vol. 7, Iss. 3, pp. 415-424
Closed Access | Times Cited: 115
A Real-World Perspective on Molecular Design
Bernd Kuhn, Wolfgang Guba, Jérôme Hert, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 9, pp. 4087-4102
Closed Access | Times Cited: 114
Methyl-containing pharmaceuticals: Methylation in drug design
Shaoyi Sun, Jianmin Fu
Bioorganic & Medicinal Chemistry Letters (2018) Vol. 28, Iss. 20, pp. 3283-3289
Closed Access | Times Cited: 110
Orexin Receptor Antagonists: New Therapeutic Agents for the Treatment of Insomnia
Anthony J. Roecker, Christopher D. Cox, Paul J. Coleman
Journal of Medicinal Chemistry (2015) Vol. 59, Iss. 2, pp. 504-530
Closed Access | Times Cited: 107
The Fragment Molecular Orbital Method Reveals New Insight into the Chemical Nature of GPCR–Ligand Interactions
Alexander Heifetz, Ewa I. Chudyk, Laura Gleave, et al.
Journal of Chemical Information and Modeling (2015) Vol. 56, Iss. 1, pp. 159-172
Open Access | Times Cited: 103
Applications of Isosteres of Piperazine in the Design of Biologically Active Compounds: Part 1
Nicholas A. Meanwell, Olivier Loiseleur
Journal of Agricultural and Food Chemistry (2022) Vol. 70, Iss. 36, pp. 10942-10971
Closed Access | Times Cited: 45
Identification of a Novel Series of Orexin Receptor Antagonists with a Distinct Effect on Sleep Architecture for the Treatment of Insomnia
Claudia Betschart, Samuel Hintermann, Dirk Behnke, et al.
Journal of Medicinal Chemistry (2013) Vol. 56, Iss. 19, pp. 7590-7607
Closed Access | Times Cited: 96
Orexin receptors as therapeutic drug targets
Anthony L. Gotter, Anthony J. Roecker, Richard Hargreaves, et al.
Progress in brain research (2012), pp. 163-188
Closed Access | Times Cited: 95
Applications of Isosteres of Piperazine in the Design of Biologically Active Compounds: Part 2
Nicholas A. Meanwell, Olivier Loiseleur
Journal of Agricultural and Food Chemistry (2022) Vol. 70, Iss. 36, pp. 10972-11004
Closed Access | Times Cited: 27
Oxazole and Isoxazole-containing Pharmaceuticals: Targets, Pharmacological Activities, and Their SAR Studies
Shanshan Li, Yujiang Mei, Luchen Jiang, et al.
RSC Medicinal Chemistry (2025)
Closed Access
Orexin Receptor Antagonists: A New Concept In CNS Disorders?
John Gatfield, Catherine Brisbare‐Roch, François Jenck, et al.
ChemMedChem (2010) Vol. 5, Iss. 8, pp. 1197-1214
Closed Access | Times Cited: 65
Discovery process and pharmacological characterization of a novel dual orexin 1 and orexin 2 receptor antagonist useful for treatment of sleep disorders
Romano Di Fabio, Annalisa Pellacani, Stefania Faedo, et al.
Bioorganic & Medicinal Chemistry Letters (2011) Vol. 21, Iss. 18, pp. 5562-5567
Closed Access | Times Cited: 51
Synthesis of 2H-1,2,3-Triazoles
Nataliya P. Belskaya, Julia Subbotina, Svetlana G. Lesogorova
Topics in heterocyclic chemistry (2014), pp. 51-116
Closed Access | Times Cited: 43
The role of orexins/hypocretins in alcohol use and abuse: an appetitive-reward relationship
Andrezza K. Kim, Robyn M. Brown, Andrew J. Lawrence
Frontiers in Behavioral Neuroscience (2012) Vol. 6
Open Access | Times Cited: 33
Measurement, Interpretation and Use of Free Ligand Solution Conformations in Drug Discovery
Charles D. Blundell, Thorsten Nowak, Martin J Watson
Progress in medicinal chemistry (2016), pp. 45-147
Closed Access | Times Cited: 31
The chemistry of the carbon–transition metal double and triple bond: Annual survey covering the year 2009
James W. Herndon
Coordination Chemistry Reviews (2010) Vol. 255, Iss. 1-2, pp. 3-100
Closed Access | Times Cited: 32
Page 1 - Next Page

Scroll to top